D

Dynavax Technologies Corp

D
DVAX
USD
-0.14
(-1.0347%)
Market Closed
75,851.00
حجم التداول
0.05
الربح لكل سهم
-
العائد الربحي
103.000
P/E
1,754,684,288.37
حجم السوق
اليوم
-1.0347%
1 اسبوع
11.490%
1 شهر
28.134%
6 اشهر
21.672%
12 اشهر
-3.041%
بداية السنة
-4.186%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Dynavax Technologies Corp

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
هل تحتاج مساعدة او لديك استفسار؟